Once-daily Oral Add-on Treatment for Patients with Parkinson’s Disease now Available in Scotland

Bial is pleased to announce that Ongentys® (opicapone) has been accepted for use within NHS Scotland following review by the Scottish Medicines Consortium (SMC) for adult patients with Parkinson's disease as adjunctive therapy to preparations of levodopa/ DOPA decarboxylase inhibitors (DDCI) with end-of-dose motor fluctuations who cannot be stabilised on those combinations. Parkinson’s disease is [...]

By |2022-01-18T13:10:53+00:00January 18th, 2022|Regional News, SH News|0 Comments


  MEMBER EVENT SATURDAY 29TH JANUARY 2022 SPONSORED BY BOOK YOUR PLACE NOW! We are delighted to be in a position to safely run our very popular member event at the end of this month for you as members. The event will FULLY comply with the current COVID restrictions, this will include mandatory face coverings, social distancing, [...]

By |2022-01-17T16:31:15+00:00January 17th, 2022|Regional News, SH News|0 Comments

PDA Calls on Employers and Pharmacist Organisations to Make a ‘New Year Resolution’ to Support the Profession’s Charity

Birmingham, UK. 07 January 2022. The PDA is encouraging pharmacy employers and pharmacists organisations to donate £1 per pharmacist employee or member to the Pharmacist Support charity and to collectively make a substantive difference to the charity's funding from 2022 onwards.Pharmacist Support is an independent, trusted charity, providing a wide variety of support services to [...]

By |2022-01-07T13:05:43+00:00January 7th, 2022|Regional News, SH News|0 Comments


An extra £240,000 will help 13 Scottish government-funded projects across health boards, third sector and other partners enhance the support available for people with chronic pain. The money will go towards a range of services, including the bladder and pelvic pain management programme, support for chronic hip, knee and back pain and support, to help [...]

By |2022-01-05T16:20:00+00:00January 5th, 2022|Regional News, SH News|0 Comments


The Omicron variant of SARS-CoV-2 represents a step-change in the COVID-19 pandemic, with record numbers of new daily infections being reported across the globe. However, quite why Omicron is spreading so rapidly remains unknown. Now, researchers at the MRC-University of Glasgow Centre for Virus Research have used laboratory experiments and real-world infection data to investigate [...]

By |2022-01-05T16:19:17+00:00January 5th, 2022|Regional News, SH News|0 Comments


Nearly £10 million has been awarded to four research projects over the next four years to improve the targeting of treatments for patients with serious illness The research will look at how treatments for those with diabetes, multiple sclerosis and liver disease, and patients in critical care, can be made more effective and targeted. The £9.75 [...]

By |2022-01-05T16:18:08+00:00January 5th, 2022|Regional News, SH News|0 Comments

Scottish pharmacy closures denying patients in deprived communities access to medicines

10 December 2021. The Pharmacists’ Defence Association (PDA) is highlighting this issue to ensure that pharmacies continue to safely offer services to the public after significant numbers of employed and locum pharmacists raised concerns that pharmacies appear to be being temporarily closed in a systematic fashion in Scotland. The PDA made Freedom of Information (FOI) [...]

By |2021-12-14T13:24:28+00:00December 14th, 2021|Regional News, SH News|0 Comments

PDA Scotland strengthens team to enhance support for members

The PDA has appointed pharmacists Maurice Hickey as Head of Policy and Paul Flynn as National Officer, for Scotland. Maurice Hickey PDA Scotland Head of Policy Maurice Hickey has a wide range of experience of practice including working in hospital and community pharmacy sectors, being a former pharmacy owner and serving on the councils of RPSGB [...]

By |2021-11-22T10:21:21+00:00November 22nd, 2021|Regional News, SH News|0 Comments

Lupin’s Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM)

Slough, UK, 4 November 2021: Global pharma major Lupin today announces that the National Institute for Health and Care Excellence (NICE) has issued the Final Appraisal Determination (FAD) recommending the routine funding of Namuscla (mexiletine) in England and Wales.1 NICE recommends Namuscla (mexiletine) within its marketing authorisation, as an option for treating the symptoms of myotonia in adults with non-dystrophic [...]

By |2021-11-04T14:19:03+00:00November 4th, 2021|Regional News, SH News|0 Comments

Register for the first #LivingDiabetesTogether webinar!

Living Diabetes together – Starting insulin Tuesday, November 9th, 2021 10:00 to 10:45 a.m. GMT Discover how you can tap into key insights in diabetes care, dialogue with patients and optimise the diabetes journey at the BD-hosted #LivingDiabetesTogether Webinar Between people living with diabetes and their healthcare support team, much can be exchanged to [...]

By |2021-11-02T11:46:11+00:00November 2nd, 2021|Regional News, SH News|0 Comments
Please Choose

Welcome to www.scothealthcare.com!
Are you a Qualified Healthcare Professional or Student?

Access to www.scothealthcare.com is solely restricted to qualified healthcare professionals and students within the sector.
Powered by Autience